Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W. Dodick, Eric Pearlman, Sheena K. Aurora et al.|Cephalalgia|2020Cited by 106